First Mercantile Trust Co. boosted its stake in shares of HealthSouth Corp. (NYSE:HLS) by 28.3% during the third quarter, Holdings Channel reports. The institutional investor owned 17,000 shares of the company’s stock after buying an additional 3,750 shares during the period. First Mercantile Trust Co.’s holdings in HealthSouth Corp. were worth $689,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. William Blair Investment Management LLC boosted its stake in shares of HealthSouth Corp. by 37.7% in the second quarter. William Blair Investment Management LLC now owns 3,061,817 shares of the company’s stock valued at $118,860,000 after buying an additional 837,747 shares during the last quarter. Bank of Montreal Can bought a new stake in shares of HealthSouth Corp. during the second quarter valued at approximately $22,389,000. Allianz Asset Management AG boosted its stake in shares of HealthSouth Corp. by 382.0% in the second quarter. Allianz Asset Management AG now owns 716,684 shares of the company’s stock valued at $27,822,000 after buying an additional 567,979 shares during the last quarter. Cumberland Partners Ltd boosted its stake in shares of HealthSouth Corp. by 178.5% in the second quarter. Cumberland Partners Ltd now owns 559,025 shares of the company’s stock valued at $21,702,000 after buying an additional 358,325 shares during the last quarter. Finally, Lord Abbett & CO. LLC boosted its stake in shares of HealthSouth Corp. by 9.2% in the second quarter. Lord Abbett & CO. LLC now owns 3,449,266 shares of the company’s stock valued at $133,901,000 after buying an additional 291,169 shares during the last quarter. 96.51% of the stock is owned by institutional investors.
HealthSouth Corp. (NYSE:HLS) traded up 0.91% during midday trading on Friday, reaching $41.15. The company had a trading volume of 218,402 shares. HealthSouth Corp. has a 12-month low of $30.26 and a 12-month high of $43.38. The company has a 50-day moving average of $40.21 and a 200-day moving average of $40.44. The stock has a market capitalization of $3.70 billion, a PE ratio of 17.15 and a beta of 0.90.
HealthSouth Corp. (NYSE:HLS) last announced its quarterly earnings results on Thursday, October 27th. The company reported $0.65 EPS for the quarter, topping the Zacks’ consensus estimate of $0.60 by $0.05. The business had revenue of $926.80 million for the quarter, compared to analysts’ expectations of $448.60 million. HealthSouth Corp. had a return on equity of 29.27% and a net margin of 6.31%. The business’s quarterly revenue was up 19.0% on a year-over-year basis. During the same period in the previous year, the firm earned $0.52 EPS. On average, analysts predict that HealthSouth Corp. will post $2.55 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Tuesday, January 17th. Shareholders of record on Tuesday, January 3rd will be paid a $0.24 dividend. The ex-dividend date is Thursday, December 29th. This represents a $0.96 dividend on an annualized basis and a yield of 2.33%. HealthSouth Corp.’s dividend payout ratio (DPR) is currently 40.17%.
A number of equities analysts have issued reports on the company. Zacks Investment Research cut HealthSouth Corp. from a “buy” rating to a “hold” rating in a report on Friday, August 5th. SunTrust Banks Inc. set a $54.00 price target on HealthSouth Corp. and gave the stock a “buy” rating in a report on Monday, August 1st. Mizuho cut HealthSouth Corp. from a “buy” rating to a “neutral” rating in a report on Wednesday, November 9th. JMP Securities restated a “buy” rating on shares of HealthSouth Corp. in a report on Sunday, September 4th. Finally, Wells Fargo & Co. restated a “buy” rating on shares of HealthSouth Corp. in a report on Sunday, September 11th. One analyst has rated the stock with a sell rating, two have given a hold rating and seven have assigned a buy rating to the company. The company currently has an average rating of “Buy” and a consensus price target of $46.57.
In related news, CFO Douglas E. Coltharp purchased 6,450 shares of the firm’s stock in a transaction on Wednesday, November 9th. The shares were acquired at an average cost of $39.14 per share, with a total value of $252,453.00. Following the purchase, the chief financial officer now directly owns 104,637 shares of the company’s stock, valued at $4,095,492.18. The purchase was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, COO Mark J. Tarr acquired 6,371 shares of the business’s stock in a transaction dated Wednesday, November 9th. The stock was acquired at an average price of $39.29 per share, for a total transaction of $250,316.59. Following the completion of the transaction, the chief operating officer now owns 238,890 shares in the company, valued at approximately $9,385,988.10. The disclosure for this purchase can be found here. 5.00% of the stock is owned by company insiders.
HealthSouth Corp. Company Profile
HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in over 30 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company’s segments include inpatient rehabilitation, and home health and hospice.